ArticleCureus2025
Self-Efficacy Among Adolescents With Sickle Cell Disease in a Central Indian Tertiary Care Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimSickle cell disease (SCD) is a major public health concern. Self-efficacy is a person's particular set of beliefs in their ability to accomplish daily life activities with symptom management. The aim of the present study was to explore the level of self-efficacy among adolescents with SCD.
methodsA descriptive cross-sectional study was conducted to assess the self-efficacy of adolescents with sickle cell disease using a purposive sampling of 300 adolescents diagnosed with SCD in a tertiary care center in east-central India. A sickle cell self-efficacy scale was used to collect data between November 2023 and April 2024. Data was analyzed using descriptive statistics and linear regression.
resultsThe mean age at which adolescents were diagnosed with SCD was 3.31 ± 0.14 years, and 69.7% (209) of adolescents were identified between the ages of one and five years. Additionally, 73% (219) of adolescents had moderate self-efficacy. The current study found that most adolescents had a moderate level of self-efficacy, and regression analysis showed that the strong predictors for higher self-efficacy levels were higher education, economic status, place of residence, and age group.
conclusionsThe adolescents had a moderate level of self-efficacy. Future interventions are recommended to help improve self-efficacy in adolescents with SCD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.